氟哌噻噸美利曲辛片聯(lián)合鹽酸帕羅西汀治療腦卒中后抑郁效果觀察
[Abstract]:Objective to investigate the clinical effect of droperazothioate meritriaxine tablets (Delixin) combined with paroxetine hydrochloride in the treatment of post-stroke depression. Methods 124 patients with post-stroke depression were randomly divided into observation group and control group. The two groups were treated with routine stroke therapy, the observation group was treated with Delixine combined with paroxetine hydrochloride on the basis of routine treatment, and the control group was treated with Delycin alone. After 28 days of continuous treatment, the efficacy and compliance of the two groups were compared with the Hamilton Depression scale score (HAMD), the ADL score (ADL) and the effective rate of treatment. Results before treatment, there was no significant difference in scores between the two groups (P0.05; After treatment, the HAMD score and ADL score in the observation group were significantly lower than those in the control group, and the effective rate in the observation group was 96.88% higher than that in the control group (81.67%). The clinical treatment compliance was 95.31% significantly higher than that of the control group (60.005%). The scores of the two groups were significantly higher than those of the control group (P 0.05). Conclusion the treatment of post-stroke depression with droperazothioate metriaxine hydrochloride combined with paroxetine hydrochloride can significantly relieve the depression symptoms, improve the compliance and quality of life of the patients, have fewer adverse reactions, and is safer than that of the simple treatment of Delixine in the treatment of patients with post-stroke depression. The effect is better and can be popularized in clinic.
【作者單位】: 河北邢臺(tái)市人民醫(yī)院;
【分類(lèi)號(hào)】:R743.3;R749.4
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 ;鹽酸帕羅西汀片說(shuō)明書(shū)[J];中國(guó)神經(jīng)免疫學(xué)和神經(jīng)病學(xué)雜志;2005年06期
2 伍文清;肖玉蓮;陳葵;;鹽酸帕羅西汀治療癲癇并發(fā)抑郁的臨床研究[J];中國(guó)康復(fù)理論與實(shí)踐;2012年02期
3 喻良;黃雨蘭;孫紅斌;;鹽酸帕羅西汀治療成年癲癇患者并發(fā)抑郁的臨床觀察[J];四川醫(yī)學(xué);2013年10期
4 楊營(yíng)軍;溫聰慧;;鹽酸帕羅西汀治療功能性消化不良97例療效觀察[J];中國(guó)醫(yī)療前沿;2009年18期
5 陳佳;唐田;王彥青;;鹽酸帕羅西汀的合成[J];中國(guó)醫(yī)藥指南;2011年19期
6 王增信,徐廣軍,趙文靜;鹽酸帕羅西汀致癲癇1例報(bào)告[J];山東精神醫(yī)學(xué);2002年03期
7 鄭獻(xiàn)召;鹽酸帕羅西汀治療老年腦卒中后抑郁癥32例觀察[J];河南實(shí)用神經(jīng)疾病雜志;2004年02期
8 闞子鳳,趙夕華,李曙光,孫冬英,劉德博;鹽酸帕羅西汀治療功能性消化不良68例臨床觀察[J];臨床薈萃;2005年14期
9 姜艷;顏紅;;口服鹽酸帕羅西汀引起口舌頰運(yùn)動(dòng)綜合征例析[J];實(shí)用中醫(yī)內(nèi)科雜志;2007年03期
10 何乾超;;鹽酸帕羅西汀合并血府逐瘀湯顆粒治療18例軀體形式疼痛障礙的臨床觀察[J];右江民族醫(yī)學(xué)院學(xué)報(bào);2010年04期
相關(guān)會(huì)議論文 前3條
1 任國(guó)賓;王靜康;尹秋響;張美景;;半水鹽酸帕羅西汀的熱行為和熱分析動(dòng)力學(xué)[A];第一屆全國(guó)化學(xué)工程與生物化工年會(huì)論文摘要集(下)[C];2004年
2 趙玉武;陳靜炯;薛波;袁加文;姚繼國(guó);;聯(lián)合應(yīng)用鹽酸帕羅西汀、氯硝安定和黛立新引起神經(jīng)阻滯劑惡性綜合征1例病例報(bào)道[A];第九次全國(guó)神經(jīng)病學(xué)學(xué)術(shù)大會(huì)論文匯編[C];2006年
3 趙艷紅;單義輝;;鹽酸帕羅西汀與阿普唑侖治療廣泛性焦慮癥的對(duì)照研究[A];中國(guó)心理衛(wèi)生協(xié)會(huì)石油石化分會(huì)成立暨第四屆石油石化心理衛(wèi)生學(xué)術(shù)研討會(huì)論文集[C];2004年
相關(guān)重要報(bào)紙文章 前1條
1 高雪;孕婦應(yīng)禁用鹽酸帕羅西汀藥物[N];中國(guó)婦女報(bào);2006年
相關(guān)博士學(xué)位論文 前1條
1 任國(guó)賓;鹽酸帕羅西汀結(jié)晶過(guò)程研究[D];天津大學(xué);2005年
相關(guān)碩士學(xué)位論文 前7條
1 宋炫;鹽酸達(dá)泊西汀治療原發(fā)性早泄的前瞻性隨機(jī)對(duì)照臨床研究[D];重慶醫(yī)科大學(xué);2015年
2 溫玉琴;鹽酸帕羅西汀腸溶緩釋制劑的研制[D];廣東藥學(xué)院;2008年
3 白才堂;鹽酸帕羅西汀緩釋膠囊的臨床前研究[D];廣東藥學(xué)院;2011年
4 史建俊;鹽酸帕羅西汀滲透泵片的藥學(xué)研究[D];青島科技大學(xué);2007年
5 宋亞靜;中國(guó)漢族人群5-羥色胺轉(zhuǎn)運(yùn)體、5-羥色胺1A受體和色氨酸羥化酶2基因多態(tài)性與抑郁癥及鹽酸帕羅西汀藥物療效關(guān)聯(lián)性研究[D];蘭州大學(xué);2008年
6 張超;帕羅西汀聯(lián)合坦索羅辛治療原發(fā)性早泄的臨床研究[D];第三軍醫(yī)大學(xué);2014年
7 王昭;腦卒中后焦慮障礙的電針治療與口服鹽酸帕羅西汀治療的臨床療效對(duì)比觀察[D];北京中醫(yī)藥大學(xué);2011年
,本文編號(hào):2407919
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/2407919.html